Journal article 359 views 278 downloads
Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies
JACC: CardioOncology, Volume: 4, Issue: 2, Pages: 238 - 253
Swansea University Author: Clive Weston
-
PDF | Version of Record
Distributed under the terms of a Creative Commons Attribution 4.0 CC BY Licence.
Download (1.83MB)
DOI (Published version): 10.1016/j.jaccao.2022.03.004
Abstract
BackgroundAlthough a common challenge for patients and clinicians, there is little population-level evidence on the prevalence of cardiovascular disease (CVD) in individuals diagnosed with potentially curable cancer.ObjectivesWe investigated CVD rates in patients with common potentially curable mali...
Published in: | JACC: CardioOncology |
---|---|
ISSN: | 2666-0873 |
Published: |
Elsevier BV
2022
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa60319 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract: |
BackgroundAlthough a common challenge for patients and clinicians, there is little population-level evidence on the prevalence of cardiovascular disease (CVD) in individuals diagnosed with potentially curable cancer.ObjectivesWe investigated CVD rates in patients with common potentially curable malignancies and evaluated the associations between patient and disease characteristics and CVD prevalence.MethodsThe study included cancer registry patients diagnosed in England with stage I to III breast cancer, stage I to III colon or rectal cancer, stage I to III prostate cancer, stage I to IIIA non-small-cell lung cancer, stage I to IV diffuse large B-cell lymphoma, and stage I to IV Hodgkin lymphoma from 2013 to 2018. Linked hospital records and national CVD databases were used to identify CVD. The rates of CVD were investigated according to tumor type, and associations between patient and disease characteristics and CVD prevalence were determined.ResultsAmong the 634,240 patients included, 102,834 (16.2%) had prior CVD. Men, older patients, and those living in deprived areas had higher CVD rates. Prevalence was highest for non-small-cell lung cancer (36.1%) and lowest for breast cancer (7.7%). After adjustment for age, sex, the income domain of the Index of Multiple Deprivation, and Charlson comorbidity index, CVD remained higher in other tumor types compared to breast cancer patients.ConclusionsThere is a significant overlap between cancer and CVD burden. It is essential to consider CVD when evaluating national and international treatment patterns and cancer outcomes. |
---|---|
Keywords: |
breast cancer; colorectal cancer; lung cancer; lymphoma; prostate cancer |
College: |
Faculty of Medicine, Health and Life Sciences |
Funders: |
This study was funded by a joint research grant from the British Heart Foundation (SP/16/5/32415) and Cancer Research UK (C53325/A21134). |
Issue: |
2 |
Start Page: |
238 |
End Page: |
253 |